Associate Professor Lesley Stafford is a clinical psychologist in psycho-oncology and women's health, with a specific interest in women with or at risk of breast cancer.

She consults in the Breast Service and Familial Cancer Centre at the Royal Melbourne Hospital as well as in private practice, and is an Associate Professor at the University of Melbourne.

Dr Shom Goel is a clinician-scientist at the University of Melbourne and Peter MacCallum Cancer Centre, with a strong interest in Translational Breast Cancer Research.

He was a guest speaker at the 2022 Breast Cancer Trials Annual Scientific Meeting and we asked Dr Goel to explain his research in CDK4/6 inhibitors and where research is going in the future.

Finding My Way is an online coping program for individuals who have been diagnosed with cancer. The program is designed to support people through their cancer diagnosis, as well as help to provide strategies to live well despite this diagnosis.

We talk with Associate Professor Lisa Beatty as she explains what 'Finding My Way' is and how it was initiated.

As part of a Clinical Fellowship project with Breast Cancer Trials, Dr Elizabeth Blackley is working on a study that involves the collection of data and the development of a registry on breast cancer incidents, treatment outcomes, and quality of life metrics in young Australian women.

The aim is to help form a streamlined model of care for young women and offer various support services to help them through their diagnosis.

While there is no way to prevent breast cancer, there are steps that can be taken to lower one's risk of being diagnosed, particularly for women with a strong family history or those who carry a gene mutation.

Dr Wanda Cui is a Medical Oncologist at the Peter MacCallum Cancer Centre and is researching into breast cancer prevention within the risk management clinic. We asked Dr Cui to explain her research on Breast Cancer Prevention.

Health economics is used in clinical trials to ensure information is being collected in the right way so that it can be provided to the minister or committees such as the Pharmaceutical Benefits Advisory Committee so that they can compare new treatments with existing treatments to decide what drugs should be funded in the public system.

We asked Associate Professor De Abreu Lorenco to explain what health economics is, and how it is currently used in clinical trials.